We are live on ! Find out more
LAB icon

Standard BioTools
LAB

119 hedge funds and large institutions have $387M invested in Standard BioTools in 2021 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 32 increasing their positions, 39 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

202% more call options, than puts

Call options by funds: $4.08M | Put options by funds: $1.35M

58% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 12

9% more capital invested

Capital invested by funds: $354M → $387M (+$32.4M)

5% more funds holding

Funds holding: 113 → 119 (+6)

0.16% more ownership

Funds ownership: 76.82% → 76.98% (+0.16%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

18% less repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 39

Holders
119
Holders Change
+6
Holders Change %
+5.31%
% of All Funds
2.08%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
19
Increased
32
Reduced
39
Closed
12
Calls
$4.08M
Puts
$1.35M
Net Calls
+$2.73M
Net Calls Change
+$2.2M

Top Buyers

1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$2.63M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$2.1M
3
N
Nuveen
North Carolina
+$1.92M
4
SAM
Silverback Asset Management
North Carolina
+$1.88M
5
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
+$1.53M

Top Sellers

1
Millennium Management
Millennium Management
New York
-$3.49M
2
CS
Candriam SCA
Luxembourg
-$1.07M
3
HSA
Hussman Strategic Advisors
Maryland
-$887K
4
Jennison Associates
Jennison Associates
New York
-$830K
5
CAM
Connacht Asset Management
New York
-$794K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$1.86M +$150K +22,822 +9%
Principal Financial Group
27
Principal Financial Group
Iowa
$1.76M -$28.2K -4,282 -2%
Connor, Clark & Lunn Investment Management (CC&L)
28
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.61M +$1.53M +233,251 +2,147%
Charles Schwab
29
Charles Schwab
California
$1.26M +$35.3K +5,362 +3%
AC
30
Alexandria Capital
Virginia
$1.24M – – –
SW
31
SkyOak Wealth
Michigan
$1.2M – – –
Two Sigma Investments
32
Two Sigma Investments
New York
$1.13M +$968K +147,209 +607%
ERSOT
33
Employees Retirement System of Texas
Texas
$1.09M +$1.09M +165,000 New
Two Sigma Advisers
34
Two Sigma Advisers
New York
$1.06M -$166K -25,200 -14%
JP Morgan Chase
35
JP Morgan Chase
New York
$1.04M -$232K -35,334 -18%
Swiss National Bank
36
Swiss National Bank
Switzerland
$1.03M – – –
AllianceBernstein
37
AllianceBernstein
Tennessee
$999K +$355K +53,965 +55%
Wells Fargo
38
Wells Fargo
California
$960K +$736K +111,882 +332%
Susquehanna International Group
39
Susquehanna International Group
Pennsylvania
$889K +$102K +15,457 +13%
PP
40
PDT Partners
New York
$843K -$452K -68,728 -35%
SFI
41
Susquehanna Fundamental Investments
Pennsylvania
$777K +$5.99K +910 +0.8%
IP
42
Intellectus Partners
California
$770K – – –
Citigroup
43
Citigroup
New York
$761K -$23.2K -3,519 -3%
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$695K +$16K +2,435 +2%
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$658K -$23K -3,489 -3%
UBS AM
46
UBS AM
Illinois
$609K -$199K -30,320 -25%
Invesco
47
Invesco
Georgia
$504K +$39.4K +5,993 +9%
CM
48
Caption Management
Oklahoma
$485K +$484K +73,525 New
CAM
49
Connacht Asset Management
New York
$429K -$794K -120,703 -65%
CS
50
Credit Suisse
Switzerland
$418K +$31.4K +4,767 +8%
1
2
3 4 5

LAB Hedge Fund Activity: Q3 2021 in Review

119 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q3 2021, worth a combined $387M — up 9.1% from $354M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new LAB positions and 12 closed out — a net gain of 7 holders — while 32 added to existing stakes and 39 trimmed.

The largest buyer was Adage Capital Partners, opening a new position worth an estimated $2.63M. The largest seller was Millennium Management, cutting an estimated $3.49M.

  • 119 institutional investors held Standard BioTools (LAB) as of Q3 2021, up from 113 in Q2 2021.
  • Funds reported $387M of Standard BioTools stock for Q3 2021, up 9.1% quarter-over-quarter.
  • 19 funds opened new Standard BioTools positions in Q3 2021 and 12 closed out, a net change of +7 holders.
  • The largest Standard BioTools buyer in Q3 2021 was Adage Capital Partners, an estimated $2.63M added.
  • The largest Standard BioTools seller in Q3 2021 was Millennium Management, an estimated $3.49M sold.

Based on aggregated 13F filings for Q3 2021.